Niosomal Favipiravir: A Novel Anthelmintic Approach
Keywords:
Anthelmintic activity, Favipiravir, NiosomesAbstract
Aim: To explore the repurposing of Favipiravir as an anthelmintic agent through the formulation of niosomal drug delivery systems using thin-film hydration method with a rotary evaporator and evaluating its efficacy against helminth parasites.
Methods: Favipiravir-loaded niosomes were prepared using the thin-film hydration method employing non-ionic surfactants (Span 60, Tween 60) and cholesterol. Characterization involved Dynamic Light Scattering (DLS), Scanning Electron Microscopy (SEM) and zeta potential analysis. Entrapment efficiency and in-vitro drug release were evaluated. Anthelmintic activity was assessed against Pheretima posthuma.
Results: The niosomal formulation exhibited a particle size of 167.5 (±1.3) nm, a PDI of 0.40 (±0.02), and a zeta potential of -30.1 (±15) mV, indicating good stability. Entrapment efficiency was 80%. In-vitro studies confirmed enhanced anthelmintic activity compared to the free drug.
Conclusion: Favipiravir-loaded niosomes demonstrated potential for repurposing as an anthelmintic agent with improved bioavailability and efficacy.
Downloads
References
Rathi V, Tiwari V, Thakur R, et al. Niosomal drug delivery systems: A review. Int J Pharm Sci Res. 2020;11(6):2483-93.
Arora D, Verma A, Kaur H. Repurposing antiviral drugs as anthelmintic agents. Future Microbiol. 2021; 16: 897-909.
Khatoon F, Wani SH, Sultana S, et al. Evaluation of niosomal drug delivery systems: Impact on the treatment of parasitic infections. J Drug Deliv Sci Technol. 2018; 48: 65-72.
Kapoor B, Kumar S, Rajput R, et al. Thin-film hydration technique for preparation of niosomes: A review. J Pharm Pharmacol. 2020; 72(9): 1167-80.
Jain S, Patel H, Patel M, et al. Niosomes: A novel drug delivery system for targeted treatment of parasitic diseases. J Pharm Sci Res. 2018; 10(4): 926-31.
Yalcin S, Ero?lu S, Erdem E. Favipiravir's antiviral and potential anthelmintic activity: A review of its broader therapeutic effects. J Antimicrob Chemother. 2021; 76(3): 655-62.
Amin H, Sayed Y, Hassan H. Niosomal formulations for the delivery of therapeutic agents in parasitic infections: A review. Drug Deliv. 2019; 26(1): 71-85.
Ouyang L, Luo Y, Zhang Y, et al. Niosomes as drug delivery carriers for the treatment of parasitic infections. J Drug Target. 2019; 27(8): 819-31.
Sharma D, Kaur P, Singh S. Applications of Favipiravir in the treatment of parasitic infections: A review. Parasitology. 2022; 149(1): 1-10.
Furuta Y, Komeno T, Nakamura T. Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase. Proc JpnAcad Ser B Phys Biol Sci. 2017; 93(7): 449-63.
Bethony J, Brooker S, Albonico M, et al. Soil-transmitted helminth infections: ascariasis, trichuriasis and hookworm. Lancet. 2006; 367(9521): 1521-32.
Barenholz Y. Doxil®—the first FDA-approved nano-drug: lessons learned. J Control Release. 2012; 160(2): 117-34.
Badr-Eldin SM, Ahmed TA, Snoussi M, et al. Preparation and evaluation of sildenafil citrate-loaded niosomes for enhanced transdermal delivery. Eur J Pharm Biopharm. 2017; 115: 189-99.
Moein M, Arabsolghar R, Ghaffari S. Formulation and evaluation of niosomes for sustained release of clarithromycin. Trop J Pharm Res. 2020; 19(4): 771-7.
Chouhan S, Sharma K, Guleria S. Niosomes: An approach to current drug delivery—a review. J Drug Deliv Ther. 2018; 8(5): 162-8.
Published
How to Cite
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Most read articles by the same author(s)
- Slesha Kumar Kosuru, Ch. Hemalatha, K. Venkat, K. Jahnavi Sravanthi, V. Kondala Rao, M.V.K Tejaswini, Santhosh Kumar Gandham, Formulation and Characterization of Copper Oxide Solid Lipid Micro-Particles , Journal of Clinical and Pharmaceutical Research: JCPR Volume:5/Issue:3 (2025)
.